A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body

NCT05879991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: zongertinib (C-14)
DRUG: zongertinib
DRUG: zongertinib (C-14)

Sponsor

Boehringer Ingelheim